Last €88.76 EUR
Change Today +0.30 / 0.34%
Volume 5.5M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
BrsaItaliana
Mexico
Frankfurt
NASDAQ GM
As of 11:38 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Olivier Charmeil

Executive Vice President of Vaccines, Sanofi
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 8 different industries.

See Board Relationships
51--

Background*

Mr. Olivier Charmeil serves as an Executive Vice President of Vaccines at Sanofi. Mr. Charmeil serves as Chief Executive Officer and President at Sanofi Pasteur, SA. He served as Executive Vice President of Pasteur Division at Sanofi. He served as Senior Vice President of Vaccines Division at Sanofi Pasteur since January 1, 2011. He served as the Senior Vice President of Pharmaceutical Operations, Asia Pacific and Japan at Sanofi-Aventis since January 1, 2008. Mr. Charmeil ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

Director, Member of Remuneration Committee, Chief Executive Officer of Sanofi Pasteur and President of Sanofi Pasteur
Former Director
2006-2011
Former Director

Education*

Unknown/Other Education
Ecole des Hautes Etudes Commerciales de Montreal
Unknown/Other Education
Institut D’études Politiques De Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €88.76 EUR +0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.